Quctipine SR 300 contains Quetiapine 300 mg in a prolonged-release (extended-release) tablet formulation. It is an atypical antipsychotic medicine prescribed for the treatment of schizophrenia, bipolar disorder (including manic and depressive episodes), and as an adjunctive therapy for major depressive disorder in certain patients. The prolonged-release formulation provides a controlled release of quetiapine over time, helping maintain stable blood levels and supporting once-daily dosing. Key Benefits Helps manage symptoms of schizophrenia, including hallucinations, delusions, and disorganized thinking. Effective in treating manic and depressive episodes associated with bipolar disorder. Extended-release technology provides consistent therapeutic effects throughout the day. Once-daily dosing may improve treatment adherence and convenience. Supports long-term management of psychiatric conditions under medical supervision. Uses Schizophrenia Bipolar disorder (mania and bipolar depression) Maintenance treatment of bipolar disorder Adjunctive treatment of major depressive disorder (as prescribed by a healthcare professional) How It Works Quetiapine works by balancing the activity of neurotransmitters such as dopamine and serotonin in the brain. This helps improve mood, stabilize emotions, reduce psychotic symptoms, and enhance overall mental functioning. Directions for Use Take exactly as prescribed by your physician. Swallow the tablet whole with water; do not crush, chew, or split the prolonged-release tablet. Take at the same time each day to maintain consistent blood levels. Do not stop the medication abruptly without consulting your healthcare provider. Storage Store below 30Β°C in a cool, dry place. Protect from moisture and direct sunlight. Keep out of reach of children. Disclaimer: Quctipine SR 300 is a prescription-only medicine and should be used only under the supervision of a qualified healthcare professional. Dosage and treatment duration should be individualized based on the patient's condition and clinical response.